GRAIL, Inc. (GRAL)
(Delayed Data from NSDQ)
$33.23 USD
+0.44 (1.34%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $33.28 +0.05 (0.15%) 5:18 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
GRAIL, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GRAL 33.23 +0.44(1.34%)
Will GRAL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GRAL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GRAL
Stock Market News for May 23, 2025
QuidelOrtho Unveils Results Manager System to Streamline Testing
GRAL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stock Market News for Feb 6, 2025
Other News for GRAL
Commit To Purchase Grail At $20, Earn 21.5% Using Options
GRAIL Inc (GRAL) to Announce Second Quarter 2025 Financial Results | GRAL stock news
GRAIL to Announce Second Quarter 2025 Financial Results | GRAL Stock News
Insider Sell Alert: Aaron Freidin Sells 8,000 Shares of GRAIL Inc (GRAL)
Supreme Court keeps element of Obamacare preventive care, Reuters reports